Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (sustain 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Real-world studies reported heterogeneous cardiovascular outcomes
Moreover, cognitive performance benefits have been attributed to the synergistic action of methylxanthines, polyphenols, and L-theanine
#weightloss #glp1 #glucagon #retatrutide #obesity #overweight The new classes of weight loss agents will definitely have their place for certain segments of the obese population, especially those with co-morbid conditions
For example, early clinical trials highlight NADs role in energy production and cellular repair, but almost none track what happens after years of repeated injections